Characteristics of Ongoing Clinical Trials for Alcohol Use Disorder Registered on ClinicalTrials.gov

JAMA Psychiatry - Tập 77 Số 10 - Trang 1081 - 2020
Joshua D. Wallach1, John H. Krystal2, Joseph S. Ross3, Stephanie S. O’Malley2
1Department of Environmental Health Sciences, Yale School of Public Health, New Haven, Connecticut
2Department of Psychiatry, Yale School of Medicine, New Haven, Connecticut
3Section of General Internal Medicine, Yale School of Medicine, New Haven, Connecticut

Tóm tắt

Từ khóa


Tài liệu tham khảo

Litten, 2016, Discovery, development, and adoption of medications to treat alcohol use disorder: goals for the phases of medications development., Alcohol Clin Exp Res, 40, 1368, 10.1111/acer.13093

Sobell, 2003, Assessing drinking outcomes in alcohol treatment efficacy studies: selecting a yardstick of success., Alcohol Clin Exp Res, 27, 1661, 10.1097/01.ALC.0000091227.26627.75

Falk, 2019, Evaluation of drinking risk levels as outcomes in alcohol pharmacotherapy trials: a secondary analysis of 3 randomized clinical trials., JAMA Psychiatry, 76, 374, 10.1001/jamapsychiatry.2018.3079

National Institute on Alcohol Abuse and Alcoholism. Strategic plan 2017-2021. Accessed January 1, 2019. https://www.niaaa.nih.gov/sites/default/files/StrategicPlan_NIAAA_optimized_2017-2020.pdf

US Food and Drug Administration. Alcoholism: developing drugs for treatment. Accessed January 1, 2019. https://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm433618.pdf

National Institute on Alcohol Abuse and Alcoholism. Division of medications development. Accessed January 1, 2019. https://www.niaaa.nih.gov/research/extramural-research/division-medications-development